Otis Worldwide's board approved a $2 billion share repurchase program to buy back the company's common stock. The company said Thursday it cancelled about $100 million remaining from a prior program, ...

Evercore ISI increased its price target on shares of Citi (NYSE:C) to $79 from the previous $69, while keeping an In Line ...

During the quarter, Citi (C)group returned a total of $2.1B to common shareholders in the form of dividends and share repurchases, the company ...

Read here for highlights on Royalty Pharma's strategic updates, share repurchase program, and dividend increase with ...

Cellnex said that it would launch a share buyback program of up to 800 million euros ($824.7 million) during the first quarter.

Willis Towers Watson's rise has been driven by solid earnings performance and moderate multiple expansion. Read why I ...

TD Cowen analyst Michael Nedelcovych reiterated a Buy rating on Royalty Pharma (RPRX – Research Report) today and set a price target of ...

As of January 10, 2025, the Company held in treasury No. 14,926,288 common shares equal to 5.81% of the total issued share capital including the common shares and the special voting shares, net of ...

As owners and operators of around 200 vessels, we offer a fully integrated shipping platform, including technical management, ...

Raises 2025 Financial Guidance Ranges for Total Revenue to $1,150 - $1,225 million, Representing YoY Growth of 16% - 23%, Adjusted EBITDA of $755 - $805 million, Representing YoY Growth of 24% - 32%, ...

The Financial Supervisory Service (FSS) has referred the case to prosecutors, determining that the large-scale capital ...

No Time Extension To Enforce CIETAC Arbitral Award Due To Delay. Legal News and Analysis - Hong Kong - Dispute Resolution - ...